Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at RBC Capital

April 7, 2026 9:02 AM EDT Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at RBC Capital

Member Login

Free News Feed